[HTML][HTML] Update on the treatment of type 2 diabetes mellitus

JJ Marín-Peñalver, I Martín-Timón… - World journal of …, 2016 - ncbi.nlm.nih.gov
To achieve good metabolic control in diabetes and keep long term, a combination of
changes in lifestyle and pharmacological treatment is necessary. Achieving near-normal …

Sulfonylureas: a new look at old therapy

PM Thulé, G Umpierrez - Current diabetes reports, 2014 - Springer
Sulfonylurea compounds were the first available oral antidiabetic agents and they remain an
important tool in our quest for optimal glucose control. The sulfonylureas stimulate the …

Association of an intensive lifestyle intervention with remission of type 2 diabetes

EW Gregg, H Chen, LE Wagenknecht, JM Clark… - Jama, 2012 - jamanetwork.com
Context The frequency of remission of type 2 diabetes achievable with lifestyle intervention
is unclear. Objective To examine the association of a long-term intensive weight-loss …

Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care

J Hippisley-Cox, C Coupland - bmj, 2016 - bmj.com
Objective To assess the risks of amputation, blindness, severe kidney failure,
hyperglycaemia, and hypoglycaemia in patients with type 2 diabetes associated with …

Hypoglycemia in patients with diabetes and renal disease

M Alsahli, JE Gerich - Journal of clinical medicine, 2015 - mdpi.com
JCM | Free Full-Text | Hypoglycemia in Patients with Diabetes and Renal Disease Next Article
in Journal Addisonian Crisis after Missed Diagnosis of Posttraumatic Hypopituitarism Next …

Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

AJ Scheen - Expert opinion on drug metabolism & toxicology, 2013 - Taylor & Francis
Introduction: People with chronic kidney disease (CKD) of stages 3–5 (creatinine clearance<
60 ml/min) represent≈ 25% of patients with type 2 diabetes mellitus (T2DM), but the …

[HTML][HTML] Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control

CCR Betônico, SMO Titan, MLC Correa-Giannella… - Clinics, 2016 - SciELO Brasil
The purpose of this study was to evaluate the therapeutic options for diabetes treatment and
their potential side effects, in addition to analyzing the risks and benefits of tight glycemic …

[HTML][HTML] Diabetes treatment in patients with renal disease: Is the landscape clear enough?

I Ioannidis - World journal of diabetes, 2014 - ncbi.nlm.nih.gov
Diabetes is the most important risk factors for chronic kidney disease (CKD). The risk of CKD
attributable to diabetes continues to rise worldwide. Diabetic patients with CKD need …

Hypoglycemia, chronic kidney disease, and diabetes mellitus

M Alsahli, JE Gerich - Mayo Clinic Proceedings, 2014 - Elsevier
Hypoglycemia is a major problem associated with substantial morbidity and mortality in
patients with diabetes and is often a major barrier to achieving optimal glycemic control …

Efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: a randomized clinical trial

C Russo, M Walicka, P Caponnetto, F Cibella… - JAMA Network …, 2022 - jamanetwork.com
Importance Evidence of effective smoking cessation interventions in patients with diabetes is
limited. The unique behavioral and metabolic characteristics of smokers with type 2 diabetes …